Universe Pharmaceuticals INC, a pharmaceutical producer and distributor in China, today announced that its ordinary shares have been approved for listing on the Nasdaq Global Market and commenced trading today under the ticker symbol "UPC".

 

The Company expects to receive aggregate gross proceeds of US$25 million from this offering.The offering is expected to close on or about March 25, 2021.

 

Headquartered in Ji'an, Jiangxi, China,the Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivative products targeting the elderly.